Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Daewoong Pharmaceutical Co. LTD. clinical trials
Part of Daewoong Co., Ltd..
The registry lists 225 studies whose lead sponsor is Daewoong Pharmaceutical Co. LTD. or one of 5 companies grouped under it. 35 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 16, 2026.
Keep track of what changes. Save the Daewoong Pharmaceutical Co. LTD. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStatus
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Daewoong Pharmaceutical Co. LTD..
- Daewoong Pharmaceutical Co. LTD.200 studiesSame company
Something wrong?
- HanAll BioPharma Co., Ltd.16 studies →Acquired
Something wrong?
- PT. Daewoong Infion3 studies →Regional office
Something wrong?
- iN Therapeutics Co., Ltd.2 studies →Subsidiary
Something wrong?
- Daewoong Bio Inc.2 studies →Subsidiary
Something wrong?
- Daewoong Group Indonesia2 studies →Regional office
Something wrong?
Focus areas
Conditions Daewoong Pharmaceutical Co. LTD. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 225. Browse all 225 →
- Study of DWP450 in Japanese Subjects With Glabellar LinesNot yet recruitingNCT07783763Phase 3
- Efficacy and Safety of DWP14012 for Long-Term Maintenance Therapy in Patients With Healed Erosive EsophagitisNot yet recruitingNCT07746518Phase 3
- Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric UlcerNot yet recruitingNCT07730138Phase 3
- A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult VolunteersRecruitingNCT07539415Phase 1
- Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy VolunteersRecruitingNCT06736587Phase 1
- To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes MellitusNot yet recruitingNCT07619833Phase 3
- Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian CancerRecruitingNCT07371104Phase 1
- Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World PracticeNot yet recruitingNCT07558707
- Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic UlcerNot yet recruitingNCT07533266Phase 4
- Noseguard for Prevention of Respiratory Infections in Real-World UseNot yet recruitingNCT07516977Not applicable
- Observational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients With Stage Ⅰ HypertensionRecruitingNCT07515599
- Efficacy and Safety of Baroezet Tablet in Korean Patients With Dyslipidemia: A Prospective Observational StudyNot yet recruitingNCT07515560
- Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting ConditionsRecruitingNCT07260851Phase 1
- Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.RecruitingNCT07267221Phase 1
- Phase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in Moderate-to-severe PsoriasisNot yet recruitingNCT07190391
- PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy VolunteersRecruitingNCT07144176Phase 1
- Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic GastritisRecruitingNCT06948487
- Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar LinesNot yet recruitingNCT07013279Phase 3
- Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or DyslipidemiaRecruitingNCT06647888
- Phase 1 Study of Drug-Drug Interactions Between DWP16001, DWC202407, and DWC202408 in Healthy AdultsNot yet recruitingNCT06644404Phase 1
- Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315Not yet recruitingNCT06592495Phase 1
- Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment PatientsNot yet recruitingNCT06606093Phase 3
- A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.RecruitingNCT06218784Phase 1
Sponsor listed in the registry: iN Therapeutics Co., Ltd.
- A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes MellitusRecruitingNCT05466643Phase 3
- To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic FunctionRecruitingNCT05747664Phase 1
- Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's DiseaseRecruitingNCT05383183Phase 4
Sponsor listed in the registry: Daewoong Bio Inc.
- Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes MellitusNot yet recruitingNCT06141980Phase 3
- Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)RecruitingNCT06121830Phase 3
- Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy SubjectsRecruitingNCT06119958Phase 1
- Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1568 in Healthy Adult VolunteersRecruitingNCT06119945Phase 1
- Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1567 in Healthy Adult VolunteersRecruitingNCT06109259Phase 1
- Evaluate the Efficacy and Safety of DWJ108JRecruitingNCT06025409Phase 3
- Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 With DWC202307 in Healthy Adult VolunteersNot yet recruitingNCT05954338Phase 1
- Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 in Healthy Adult VolunteersNot yet recruitingNCT05954247Phase 1
- To Evaluate the Effect of Food on the Safety and PK Characteristics of DWP16001 in Healthy Adult VolunteersRecruitingNCT05797922Phase 1
- Functional Outcomes After Hyaluronic Acid Injections Following ArthroscopyCompletedNCT07468045Not applicable
Sponsor listed in the registry: Daewoong Group Indonesia
- Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPFActive, not recruitingNCT05389215Phase 2
- Efficacy and Safety of Leuprolide Acetate 45 mg in Subjects With Central Precocious PubertyActive, not recruitingNCT06926933Phase 4
Sponsor listed in the registry: HanAll BioPharma Co., Ltd. · HanAll BioPharma Co., Ltd. — acquired company within the Daewoong Pharmaceutical Co. LTD. group
- Efficacy and Safety of DWC202404 and DWC202314 in Patients With HypertensionCompletedNCT06682000Phase 3
- A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and HyperlipidemiaCompletedNCT05643508Phase 3
- A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With HypertensionCompletedNCT06671392Phase 3
- Allogeneic Human Mesenchymal Stem Cell Infusion for Frailty PatientCompletedNCT07449364Not applicable
Sponsor listed in the registry: Daewoong Group Indonesia
- Drug-Drug Interaction Study to Evaluate the Effect of DWC202511 or DWC202512 With DWP16001 in Healthy AdultsCompletedNCT07213310Phase 1
- A Study Assessing the Safety of Oral ATH-399A in Healthy Adult ParticipantsCompletedNCT06088784Phase 1
Sponsor listed in the registry: HanAll BioPharma Co., Ltd. · HanAll BioPharma Co., Ltd. — acquired company within the Daewoong Pharmaceutical Co. LTD. group
- Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter PyloriCompletedNCT06751121Phase 3
- PK and Safety Comparison of DWJ445 and DWC202506 in Healthy VolunteersCompletedNCT07256600Phase 1
- A Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE TabCompletedNCT05660122
- Effect of Linking Data Using Smartphone Application, 'Well Check', on Clinical Outcomes in Patients With Type 2 Diabetes MellitusActive, not recruitingNCT06419816
- To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients With Type II Diabetes MellitusActive, not recruitingNCT05926414
- Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes MellitusActive, not recruitingNCT06427083